UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F (Mark One) ☐ REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2022 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period fromto OR ☐ SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 For the Month of April 2023 Commission File Number: 001-39822 Pharming Group N.V. (Exact Name of Registrant as Specified in Its Charter) Darwinweg 24 2333 CR Leiden The Netherlands (Address of principal executive offices) Indicate by check mark whether the registrant files or will file annual reports ...

Pharming Group N.V. (OTCPK:PHGUF) Q4 2022 Earnings Call Transcript March 16, 2023 8:30 AM ET Company Participants Sijmen de Vries - Executive Director & Chief Executive Officer Anurag Relan - Chief Medical Officer Jeroen Wakkerman - Chief Financial Officer Stephen Toor - Chief Commercial Officer & General Manager Americas Conference Call Participants Sushila Hernandez - Kempen Joe Pantginis - H.C. Wainwright Hartaj Singh - Oppenheimer Christian Glennie - Stifel Operator Hello, and welcome to today's Pharmin ...

Pharming Group N.V. Full Year 2022 Financial Results March 16, 2023 NASDAQ: PHAR | EURONEXT Amsterdam: PHARM mm Forward-looking statements 2 This press release may contain forward-looking statements. Forward-looking statements are statements of future expectations that are based on management's current expectations and assumptions and involve known and unknown risks and uncertainties that could cause actual results, performance, or events to differ materially from those expressed or implied in these stateme ...

Pharming Group N.V. (OTCPK:PHGUF) Q3 2022 Earnings Conference Call October 27, 2022 7:30 AM ET Company Participants Sijmen de Vries - Chief Executive Officer Anurag Relan - Chief Medical Officer Jeroen Wakkerman - Chief Financial Officer Conference Call Participants Hartaj Singh - Oppenheimer & Co. Joseph Pantginis - H.C. Wainwright Simon Scholes - First Berlin Operator Hello, and welcome to Pharming's Nine Months 2022 Results Call. My name is Lauren, and I will be coordinating your call today. [Operator In ...

Pharming Group N.V. (OTCPK:PHGUF) First Half 2022 Earnings Conference Call August 4, 2022 7:30 AM ET Company Participants Sijmen de Vries – Chief Executive Officer Anurag Relan – Chief Medical Officer Jeroen Wakkerman – Chief Financial Officer Conference Call Participants Joe Pantginis – H.C. Wainwright Hartaj Singh – Oppenheimer & Co. Simon Scholes – First Berlin Jacob Mekhael – Kempen Operator Hello, everybody, and welcome to the Pharming's First Half of 2022 Results Call. My name is Sam, and I'll be coor ...

Pharming Group N.V. H1 2022 Financial Results Analyst Call August 4, 2022 NASDAQ: PHAR | EURONEXT Amsterdam: PHARM 1177 Forward looking statements 2 This presentation may contain forward-looking statements. Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, our development plans, our clinical results and other future condit ...

Pharming Group N.V. (OTCPK:PHGUF) Q1 2022 Earnings Conference Call May 12, 2022 7:30 AM ET Company Participants Sijmen de Vries - CEO Jeroen Wakkerman - CFO Anurag Relan - Chief Medical Officer Conference Call Participants Joe Pantginis - H.C. Wainright Hartaj Singh - Oppenheimer & Co. Christian Glennie - Stifel Simon Scholes - First Berlin Equity Operator Hello, everyone, and welcome to the Pharming's First Quarter Results Conference Call. My name is Victoria, and I'll be coordinating your call today. [Ope ...

Pharming Group N.V. (OTCPK:PHGUF) Full Year 2021 Earnings Conference Call March 17, 2022 9:00 AM ET Company Participants Sijmen Vries - Executive Director and Chief Executive Officer Jeroen Wakkerman - Chief Financial Officer Anurag Relan - Chief Medical Officer Conference Call Participants Hartaj Singh - Oppenheimer & Co Joe Pantginis - H.C. Wainright Alex Cogut - Kempen Christian Glennie - Stifle Operator Hello and welcome to Pharming’s Full Year 2021 Results call. My name is Jordan and I’ll be coordinat ...

Pharming Group N.V. (OTCPK:PHGUF) Q3 2021 Results Conference Call October 28, 2021 7:30 AM ET Company Participants Sijmen de Vries - CEO Dr. Anurag Relan - Chief Medical Officer Jeroen Wakkerman - CFO Conference Call Participants Hartaj Singh - Oppenheimer & Co. Joe Pantginis - H.C. Wainright Simon Scholes - First Berlin Sijmen de Vries Thank you very much. Good morning, good afternoon. Welcome to our nine months 2021 results call. I will be happy taking you through the call with a couple of my colleagues, ...